Avelumab in Patients With Metastatic Colorectal Cancer.
Jason Mark RedmanGeraldine O'Sullivan CoyneClay T ReedRavi A MadanJulius StraussSeth J SteinbergJennifer MartéLisa M CordesChristopher HeeryJames L GulleyPublished in: The oncologist (2023)
As demonstrated with other anti-PD-1/PD-L1 monoclonal antibodies, avelumab is not active in unselected patients with mCRC (ClinicalTrials.gov Identifier: NCT01772004).
Keyphrases